Sphincter preservation in four consecutive phase II studies of preoperative chemoradiation: Analysis of 247 T3 rectal cancer patients

Tumori

Volumn 93, Issue 2, 2007, Pages 160-169

  Gambacorta, Maria Antonietta ^a   Valentini, Vincenzo ^a,c   Coco, Claudio ^a   Manno, Alberto ^a   Doglietto, Giovanni B ^a   Ratto, Carlo ^a   Cosimelli, Maurizio ^b   Miccichè, Francesco ^a   Maurizi, Francesca ^a   Tagliaferri, Luca ^a   Mantini, Giovanna ^a   Balducci, Mario ^a   La Torre, Giuseppe ^a   Barbaro, Brunella ^a   Picciocchi, Aurelio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c Istituto di Radiologia di Universita Cattolica del Sacro Cuore di Roma   (Italy)

Author keywords

Combined modality therapy; Infusional chemotherapy; Preoperative radiotherapy; Rectal neoplasms; Sphincter saving procedure

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN; OXALIPLATIN; RALTITREXED;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PHASE 2 CLINICAL TRIAL; PRESERVATION; PROGNOSIS; RADIATION DOSE; RECTUM CANCER; TREATMENT RESPONSE;

EID: 34249871123     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160709300209     Document Type: Article

References (44)

1. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R: German Rectal Cancer Study Group: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 351: 1731-1740, 2004.
2. Bosset JF, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC, Collette L: Preoperative radiotherapy (Preop RT) in rectal cancer: effect and timing of additional chemotherapy (CT) 5 year results of the EORTC 22921 trial. J Clin Oncol, 23 (16S), Part I of II (June 1 Suppl): 3505, 2005.
3. Gerard J, Bonnetain F, Conroy T, Chapet O, Bouche O, Closon-Dejardin M, Untereiner M, Leduc B, Francois E, Bedenne L: Preoperative (preop) radiotherapy (RT) + 5-fluorouracil/folinic acid in T3-4 rectal cancers: results of the FFCD 9203 randomized trial. J Clin Oncol, 23 (16S), Part I of II (June 1 Suppl): 3504, 2005.
4. Valentini V, Coco C, Cellini N, Picciocchi A, Genovesi D, Mantini G, Barbaro B, Cogliandolo S, Mattana C, Ambesi-Impiombato F, Tedesco M, Cosimelli M: Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys, 40: 1067-1075, 1998.
5. Valentini V, Coco C, Cellini N, Picciocchi A, Rosetto ME, Mantini G, Marmiroli L, Barbaro B, Cogliandolo S, Nuzzo G, Tedesco M, Ambesi Impiombato F, Cosimelli M, Rotman M: Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys, 45: 1175-1184, 1999.
6. Valentini V, Doglietto GB, Morganti AG, Turriziani A, Smaniotto D, De Santis M, Ratto C, Sofo L, Cellini N: Preoperative chemoradiation with raltitrexed for T2/N + and T3/N + rectal cancers: a phase I study. Eur J Cancer, 37: 2050-2055, 2001.
7. Gambacorta MA, Valentini V, Morganti AG, Mantini G, Miccichè F, Ratto C, Di Miceli D, Rotondi F, Alfieri S, Doglietto GB, Vargas JG, De Paoli A, Rossi C, Cellini N: Chemoradiation with raltitrexed (Tomudex) in preoperative treatment of stage II-III resectable rectal cancer: a phase II study. Int J Radiat Oncol Biol Phys, 60: 130-138, 2004.
8. Gambacorta MA, Valentini V, Coco C, Morganti AG, Smaniotto D, Miccichè F, Mantini G, Barbaro B, Garcia-Vargas JE, Magistrelli P, Picciocchi A, Cellini N: Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: a phase I and II study. Int J Radiat Oncol Biol Phys; 60: 139-148, 2004.
9. UICC International Union Against Cancer TNM Classification of Malignant Tumours, Fourth Edition, 2nd Revision, Springer Verlag, 1992.
10. Marano P, Barbaro B, De Franco A, Vecchioli A, Cellini N, Valentini V, Coco C, Doglietto GB, Vecchio FM: Diagnostic and therapeutic integration in rectal cancer. Preliminary notes. Radiol Med (Torino), 84: 261-273, 1992.
11. International Commission on Radiation Units and Measurements. ICRU Report 50: Prescribing, recording and reporting photon beam therapy, 1993.
12. International Commission on Radiation Units and Measurements. ICRU Report 62: prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50), 1999.
13. Capirci C, Polico C, Mandoliti G: Dislocation of small bowel volume within box pelvic treatment fields, using new "up down table" device. Int J Radiat Oncol Biol Phys, 51: 465-473, 2001.
14. Sofo L, Ratto C, Doglietto GB, Valentini V, Trodella L, Ippoliti M, Nucera P, Merico M, Bellantone R, Bossola M, Cellini N, Crucitti F: Intraoperative radiation therapy in integrated treatment of rectal cancers. Results of phase II study. Dis Colon Rectum, 39: 1396-1403, 1996.
15. Machover D, Schwarzenberg L, Goldschmidt E, Tourani JM, Michalski B, Hayat M, Dorval T, Misset JL, Jasmin C, Maral R, Mathe G: Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study. Cancer Treat Rep, 66: 1803-1807, 1982.
16. Miller AB: Reporting result of cancer treatment. Cancer, 47: 207-214, 1981.
17. Valentini V, Coco C, Cellini N, Picciocchi A, Genovesi D, Mantini G, Barbaro B, Cogliandolo S, Mattana C, Ambesi Impiombato F, Tedesco M, Cosimelli M: Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys, 40: 1067-1075, 1998.
18. Minsky BD, Cohen AM, Enker WE, Sigurdson E: Phase I/II trial of pre-operative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer. Int J Radiat Oncol Biol Phys, 23: 387-392, 1992.
19. Brown MB, Benedetti JK: Sampling behavior of tests for correlation in two-way contingency tables. J Am Stat Assoc, 72: 309-315, 1977.
20. 2 tests. Biometrics, 10: 417-441, 1954.
21. Cox DR: Regression model and life tables. J Royal Stat Soc Series B, 34: 187-220, 1972.
22. Hosmer DW, Taber S, Lemeshow S: The importance of assessing the fit of logistic regression models: a case study. Am J Public Health, 81: 1630-1635, 1991.
23. Graf W, Dahlberg M, Osman MM, Holmberg L, Pahlman L, Glimelius B: Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients. Radiother Oncol, 43: 133-137, 1997.
24. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJ, Leer JW, Van Krieken JH: Pathology Review Committee and the Cooperative Clinical Investigators. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol, 19: 1976-1984, 2001.
25. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Pudelko M, Kryj M, Oledzki J, Szmeja J, Sluszniak J, Serkies K, Kladny J, Pamucka M, Kukolowicz P: Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomized trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy. Radiother Oncol, 72: 15-24, 2004.
26. Hyams DM, Mamounas EP, Petrelli N, Rockette H, Jones J, Wieand HS, Deutsch M, Wickerham L, Fisher B, Wolmark N: A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03. Dis Colon Rectum, 40: 131-139, 1997.
27. Wagman R, Minsky BD, Cohen AM, Guillem JG, Paty PP: Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys, 42: 51-57, 1998.
28. Crane CH, Skibber JM, Feig BW, Vauthey JN, Thames HD, Curley SA, Rodriguez-Bigas MA, Wolff RA, Ellis LM, Delclos ME, Lin EH, Janjan NA: Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer, 97: 517-524, 2003.
29. Kirwan WO, Turnbull RB Jr, Fazio VW, Weakley FL: Pullthrough operation with delayed anastomosis for rectal cancer. Br J Surg, 65: 695-699, 1978.
30. Luna Perez P, Rodriguez Ramirez S, Hernandez Pacheco F, Gutierrez De La Barrera M, Fernandez R, Labastida S: Anal sphincter preservation in locally advanced low rectal adenocarcinoma after preoperative chemoradiation therapy and coloanal anastomosis. J Surg Oncol, 82: 3-9, 2003.
31. Kuvshinoff B, Maghfoor I, Miedema B, Bryer M, Westgate S, Wilkes J, Ota D: Distal margins requirements after preoperative chemoradiotherapy for distal rectal carcinoma: are < 1 cm sufficient? Ann Surg Oncol, 8: 163-169, 2001.
32. Kim JS, Kim JS, Cho MJ, Song KS, Yoon WH: Preoperative chemoradiation using oral capacitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phis, 54: 403-408, 2002.
33. Dupuis O, Vié B, Lledo G, Hennequin C, Noirclerc M, Bennamoun M, Pavlovitch JM, Jacob JH: Capecitabine (X) chemoradiation (CRT) in the preoperative treatment of patients (pts) with rectal adenocarcinoma: A phase II GERCOR trial. J Clin Oncol, 14 (July 15 Suppl): 3538, 2004.
34. Blackstock W, Tepper JE, Douglas Case L: In vitro and in vivo radiosensitization of colon cancer cells by cis-[(1R,2R)-1-2-cyclohexanediamine- N,N′] [oxalato(2-)-OO] platinum (oxaliplatin). Int J Mol Med, 10 (Suppl 1): S68, 2002.
35. Gerard JP, Chapet O, Nemoz C, Romestaing P, Mornex F, Coquard R, Barbet N, Atlan D, Adeleine P, Freyer G: Pre-operative concurrent chemoradiotherapy in locally advanced rectal cancer with high dose radiation and oxaliplatin containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol, 21: 1119-1124, 2003.
36. Rodel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R: Phase I/II trial of capecitabine, oxaliplatin and radiation for rectal cancer. J Clin Oncol, 21: 3098-3104, 2003.
37. Mehta VK, Cho C, Ford JM, Jambalos C, Poen J, Koong A, Lin A, Bastidas JA, Young H, Dunphy EP, Fisher G: Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil and weekly CPT11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys, 55: 132-137, 2003.
38. Temple LK, Wong WD, Minsky B: The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation. Semin Radiat Oncol, 13: 469-477, 2003.
39. Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Martenson JA, Illstrup DM: The long term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg, 220: 676-682, 1994.
40. Valero G, Lujan JA, Hernandez Q, De Las Heras M, Pellicer E, Serrano A, Parrilla P: Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications. Int J Colorectal Dis, 18: 495-499, 2003.
41. Rouanet P, Saint Aubert B, Lemanski C, Senesse P, Gourgou S, Quenet F, Ycholu M, Kramar A, Dubois J: Restorative and non restorative surgery for low rectal cancer after high-dose radiation: long term oncologic and functional results. Dis Colon Rectum, 45: 305-313, 2002.
42. Valentini V, Coco C, Cellini N, Picciocchi A, Fares MC, Rosetto ME, Mantini G, Morganti AG, Barbaro B, Cogliandolo S, Nuzzo G, Tedesco M, Ambesi Impiombato F, Cosimelli M, Rotman M: Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys, 51: 371-383, 2001.
43. Grumann MM, Noack EM, Hoffman I A: Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg, 233: 149-156, 2001.
44. Glimelius B, Gronberg H, Jarhult J, Wallgren A, Cavallin Stahl E: A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol, 42: 476-492, 2003.